Where does the data come from?

U.S. FDA National Drug Code (NDC) Directory via openFDA. Official record: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=83059-0182

Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp: new drug for further processing listing

Q: How to monitor Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp and peer other records

FdaNdcDirectoryPulse lists new FdaNdcDirectoryPulse records from U.S. FDA National Drug Code (NDC) Directory via openFDA as they are published; a free weekly email digest and paid alerts follow records like this one.

Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp: new drug for further processing listing. Dated 61 days ago, it serves as a historical benchmark. Score 15/100. As of 2026-11-03, from U.S. FDA National Drug Code (NDC) Directory via openFDA.

Data as of 2026-11-03 · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA

Free preview: all 9 published fields of this record are shown below. Locked: 103 related FdaNdcDirectoryPulse records and the 5-column CSV export.

Field	Value
Generic name	Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg
NDC	83059-0182
Labeler	Shield Pharmaceuticals Corp
Product type	DRUG FOR FURTHER PROCESSING
Approval pathway	DRUG FOR FURTHER PROCESSING
Dosage form	TABLET
Active ingredients	ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1
Marketing start	2026-09-04
Package configurations	1
Peer records CSV (104 records)	🔒 Click to unlock →
CRM-ready export with official source URLs	🔒 Click to unlock →

View the official record

Markdown version

Watch Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals + all 104 records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL

Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
Record date: 2026-09-04
Data refreshed: 2026-11-03
Refunds on request within 14 days

Search all records free →

Top FdaNdcDirectoryPulse records (DRUG FOR FURTHER PROCESSING first): Lutetium (Lu 177) chloride (Lutetium (Lu 177) chloride) by C · Olibanum 1X (Olibanum 1X) by US Tinctures, LLC · ACYCLOVIR (ACYCLOVIR) by Isomedix Operations Inc · Water (Water) by Siegfried Hameln GmbH · Exosomes (Exosomes) by Regenerative Cell Research Institute · Browse all by state and category →

LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Tue, 03 Nov 2026 18:09:00 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

<a href="https://zalwin.com/report/fdandcdirectorypulse/acetaminophen-325-mg-guaifenesin-200-mg-phenylephrine-hcl-5-drug-for-further-processing--ndc-83059-0182" rel="noopener"><img src="https://zalwin.com/badge/listed.svg" alt="Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp on Zalwin public records" width="150" height="28"></a>

Peer benchmark and outreach value: Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp and 104 DRUG FOR FURTHER PROCESSING peers

Your role Typical deal size (USD) Assumed reply-to-deal rate (%)

DRUG FOR FURTHER PROCESSING FdaNdcDirectoryPulse records like this one: 104
Timing: Low: older than 30 days
Estimated pipeline if you contact every DRUG FOR FURTHER PROCESSING peer: $20,800 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

15 / 100 Launch Signal Score

What is the FdaNdcDirectoryPulse record for Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp?

Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg by Shield Pharmaceuticals Corp: new drug for further processing listing (DRUG FOR FURTHER PROCESSING) starting 2026-09-04.

How does Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp compare to other FdaNdcDirectoryPulse records?

It is 61 days old; check the official source for later updates before acting. Its Launch Signal Score of 15/100 is modest; treat it as background rather than a priority.

Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp vs. top 3 peers

Organization	Location	Record date
Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp	DRUG FOR FURTHER PROCESSING	2026-09-04
Water (Water) by Siegfried Hameln GmbH	DRUG FOR FURTHER PROCESSING	2026-10-19
Donanemab (Donanemab) by BSP Pharmaceuticals S.p.A.	DRUG FOR FURTHER PROCESSING	2026-09-22
apitegromab (apitegromab) by Catalent Pharma Solutions, LLC	DRUG FOR FURTHER PROCESSING	2026-09-11

Related records

FdaNdcDirectoryPulse: Other

How to monitor Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp and peer other records

Get new FdaNdcDirectoryPulse records like Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg) by Shield Pharmaceuticals Corp by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new listings in your categories

FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.